Protocol1 from Anti–LAG-3 Antibody LBL-007 plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial

2026 Open access

Read full text
Authors: Dongchen Sun, Gang Chen, Yu Zhen Chen, Song Qu, Lei Liu, Kunyu Yang, Jingao Li, Lisha Chen, Xiaoming Huang, Haisheng Zhu, Wenjun Tang, Rensheng Wang
+11 more Yaqian Han, Desheng Hu, Jin Gao, Xiaozhong Chen, Hailin Xiong, Wu Chen, Bin Fan, Shengli Cai, Xiaoqiang Kang, Li Zhang, Yunpeng Yang
DOI: 10.1158/1078-0432.31353232
Cited by: 0

Fields of Study & Subjects

Head and Neck Cancer Studies Cancer Immunotherapy and Biomarkers Head and Neck Surgical Oncology

Publication details

Publication date
17 February 2026
Language
EN